A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment - PubMed (original) (raw)
doi: 10.1371/journal.pone.0043918. Epub 2012 Sep 4.
Xue Xu, Jinan Wang, Hua Yu, Xia Wang, Hongjun Yang, Haiyu Xu, Shihuan Tang, Yan Li, Ling Yang, Luqi Huang, Yonghua Wang, Shengli Yang
Affiliations
- PMID: 22962593
- PMCID: PMC3433480
- DOI: 10.1371/journal.pone.0043918
A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment
Xiuxiu Li et al. PLoS One. 2012.
Abstract
Compound Danshen Formula (CDF) is a widely used Traditional Chinese Medicine (TCM) which has been extensively applied in clinical treatment of cardiovascular diseases (CVDs). However, the underlying mechanism of clinical administrating CDF on CVDs is not clear. In this study, the pharmacological effect of CDF on CVDs was analyzed at a systemic point of view. A systems-pharmacological model based on chemical, chemogenomics and pharmacological data is developed via network reconstruction approach. By using this model, we performed a high-throughput in silico screen and obtained a group of compounds from CDF which possess desirable pharmacodynamical and pharmacological characteristics. These compounds and the corresponding protein targets are further used to search against biological databases, such as the compound-target associations, compound-pathway connections and disease-target interactions for reconstructing the biologically meaningful networks for a TCM formula. This study not only made a contribution to a better understanding of the mechanisms of CDF, but also proposed a strategy to develop novel TCM candidates at a network pharmacology level.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Similar articles
- Systems-Pharmacology Dissection of Traditional Chinese Medicine Compound Saffron Formula Reveals Multi-scale Treatment Strategy for Cardiovascular Diseases.
Liu J, Mu J, Zheng C, Chen X, Guo Z, Huang C, Fu Y, Tian G, Shang H, Wang Y. Liu J, et al. Sci Rep. 2016 Jan 27;6:19809. doi: 10.1038/srep19809. Sci Rep. 2016. PMID: 26813334 Free PMC article. - [Study on mechanism of Salvia miltiorrhiza treating cardiovascular disease through auxiliary mechanism elucidation system for Chinese medicine].
He SB, Zhang BX, Wang HH, Wang Y, Qiao YJ. He SB, et al. Zhongguo Zhong Yao Za Zhi. 2015 Oct;40(19):3713-7. Zhongguo Zhong Yao Za Zhi. 2015. PMID: 26975090 Chinese. - Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.
Wang L, Ma R, Liu C, Liu H, Zhu R, Guo S, Tang M, Li Y, Niu J, Fu M, Gao S, Zhang D. Wang L, et al. Curr Pharm Des. 2017;23(7):1077-1097. doi: 10.2174/1381612822666161010105242. Curr Pharm Des. 2017. PMID: 27748194 Free PMC article. Review. - System-Pharmacology Dissection of Traditional Chinese herbs SINI Decoction for Treatment of Cardiovascular Diseases.
Shu Z, Wu T, Shahen M, Guo Z, Shu J, Wang HE, Shar AH, Farag MR, Alagawany M, El-Hack MEA, Liu C. Shu Z, et al. An Acad Bras Cienc. 2019 Sep 23;91(3):e20180424. doi: 10.1590/0001-3765201920180424. eCollection 2019. An Acad Bras Cienc. 2019. PMID: 31553364 - Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases.
Chen W, Chen G. Chen W, et al. Curr Pharm Des. 2017;23(34):5125-5135. doi: 10.2174/1381612823666170822101112. Curr Pharm Des. 2017. PMID: 28828985 Review.
Cited by
- Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae.
Zhang J, Li Y, Chen SS, Zhang L, Wang J, Yang Y, Zhang S, Pan Y, Wang Y, Yang L. Zhang J, et al. Int J Mol Sci. 2015 Jan 28;16(2):2913-41. doi: 10.3390/ijms16022913. Int J Mol Sci. 2015. PMID: 25636035 Free PMC article. - Synergistic study of a Danshen (Salvia Miltiorrhizae Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination on cell survival in EA.hy926 cells.
Zhou X, Razmovski-Naumovski V, Kam A, Chang D, Li CG, Chan K, Bensoussan A. Zhou X, et al. BMC Complement Altern Med. 2019 Feb 21;19(1):50. doi: 10.1186/s12906-019-2458-z. BMC Complement Altern Med. 2019. PMID: 30791910 Free PMC article. - Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches.
Luo S, Lenon GB, Gill H, Hung A, Dias DA, Li M, Nguyen LT. Luo S, et al. PLoS One. 2020 Apr 29;15(4):e0231815. doi: 10.1371/journal.pone.0231815. eCollection 2020. PLoS One. 2020. PMID: 32348327 Free PMC article. - An analysis of chemical ingredients network of Chinese herbal formulae for the treatment of coronary heart disease.
Ding F, Zhang Q, Ung CO, Wang Y, Han Y, Hu Y, Qi J. Ding F, et al. PLoS One. 2015 Feb 6;10(2):e0116441. doi: 10.1371/journal.pone.0116441. eCollection 2015. PLoS One. 2015. PMID: 25658855 Free PMC article. - Synergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current Research.
Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, Bensoussan A. Zhou X, et al. Front Pharmacol. 2016 Jul 12;7:201. doi: 10.3389/fphar.2016.00201. eCollection 2016. Front Pharmacol. 2016. PMID: 27462269 Free PMC article. Review.
References
- World Health Organization website. Available: http://www.who.int/topics/cardiovascular_diseases/en/. Accessed 2012 June 20.
- Xu J, Wu H (2009) Chinese herbal medicine and acupuncture for the treatment of cardiovascular disease. J Geriatr Cardiol 6: 56–61.
- State Pharmacopoeia Commission of the PRC (2005) Pharmacopoeia of People's Republic of China, 2005. Beijing: Chemical Industry Press.
- Ding N (2002) Development and clinical application of compound danshen dripping pills. Chin Tradit Herb Drugs 33: 1147–1148.
- Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS (1998) Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Thromb Vasc Biol 18: 481–486. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
This work was supported by the National Natural Science Fund of China (Grant No. 31170796), the Special Research Foundation for Traditional Chinese Medicine (Grant No. 200907001-5), as well as the Innovation Fund of Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
LinkOut - more resources
Full Text Sources